101. The role of BMP4 signaling in trophoblast emergence from pluripotency
- Author
-
R. Michael Roberts, Toshihiko Ezashi, Jasmine Temple, Joseph R. Owen, Francesca Soncin, and Mana M. Parast
- Subjects
Pluripotent Stem Cells ,Biochemistry & Molecular Biology ,Physiology ,Placenta ,Trophoblast stem cells ,1.1 Normal biological development and functioning ,Clinical Sciences ,Bone Morphogenetic Protein 4 ,Regenerative Medicine ,Article ,Cellular and Molecular Neuroscience ,Mice ,Pregnancy ,Underpinning research ,Animals ,Humans ,Naive pluripotency ,Molecular Biology ,Cytotrophoblast ,Pharmacology ,Pediatric ,Epiblast ,Bone Morphogenetic Protein ,Cell Differentiation ,Cell Biology ,Stem Cell Research ,Naïve pluripotency ,Trophoblasts ,Primed pluripotency ,Molecular Medicine ,Trophectoderm ,Female ,Inner cell mass ,Stem Cell Research - Nonembryonic - Non-Human ,Biochemistry and Cell Biology ,Signal Transduction - Abstract
The Bone Morphogenetic Protein (BMP) signaling pathway has established roles in early embryonic morphogenesis, particularly in the epiblast. More recently, however, it has also been implicated in development of extraembryonic lineages, including trophectoderm (TE), in both mouse and human. In this review, we will provide an overview of this signaling pathway, with a focus on BMP4, and its role in emergence and development of TE in both early mouse and human embryogenesis. Subsequently, we will build on these in vivo data and discuss the utility of BMP4-based protocols for in vitro conversion of primed vs. naïve pluripotent stem cells (PSC) into trophoblast, and specifically into trophoblast stem cells (TSC). PSC-derived TSC could provide an abundant, reproducible, and ethically acceptable source of cells for modeling placental development.
- Published
- 2022